1
|
Zou J, Zhao Z, Zhang G, Zhang Q, Pyykkö I. MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere’s disease and vascular congestion over the endolymphatic sac. J Otol 2022; 17:175-181. [PMID: 35847575 PMCID: PMC9270563 DOI: 10.1016/j.joto.2022.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 03/05/2022] [Accepted: 03/09/2022] [Indexed: 10/25/2022] Open
|
2
|
Karim S, Saharti S, Alganmi N, Mirza Z, Alfares A, Turkistany S, Al-Attas M, Noureldin H, Al Sakkaf K, Abusamra H, Al-Qahtani M, Abuzenadah A. Two Novel Homozygous HPS6 Mutations (Double Mutant) Identified by Whole-Exome Sequencing in a Saudi Consanguineous Family Suspected for Oculocutaneous Albinism. Life (Basel) 2021; 12:life12010014. [PMID: 35054407 PMCID: PMC8779141 DOI: 10.3390/life12010014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2021] [Revised: 12/11/2021] [Accepted: 12/13/2021] [Indexed: 11/28/2022] Open
Abstract
Background: Oculocutaneous albinism (OCA) is an autosomal recessive disorder of low or missing pigmentation in the eyes, hair, and skin. Multiple types of OCA, including Hermansky-Pudlak syndrome 6 (HPS6), are distinguished by their genetic cause and pigmentation pattern. HPS6 is characterized by OCA, nose bleeding due to platelet dysfunction, and lysosome storage defect. To date, 25 disease-associated mutations have been reported in the HPS6 gene. Methods: DNA was extracted from proband, and whole-exome sequencing (WES) was performed using the Illumina NovaSeq platform. Bioinformatic analysis was done with a custom-designed filter pipeline to detect the causative variant. We did Sanger sequencing to confirm the candidate variant and segregation analysis, and protein-based structural analysis to evaluate the functional impact of variants. Result: Proband-based WES identified two novel homozygous mutations in HPS6 (double mutation, c.1136C>A and c.1789delG) in an OCA suspect. Sanger sequencing confirmed the WES results. Although no platelet and/or lysosome storage defect was detected in the patient or family, an oculocutaneous albinism diagnosis was established based on the HPS6 mutations. Structural analysis revealed the transformation of abnormalities at protein level for both nonsense and frameshift mutations in HPS6. Conclusion: To the best of our knowledge, the double mutation in HPS6 (p.Ser379Ter and p.Ala597GlnfsTer16) represents novel pathogenic variants, not described previously, which we report for the first time in the Saudi family. In silico analyses showed a significant impact on protein structure. WES should be used to identify HPS6 and/or other disease-associated genetic variants in Saudi Arabia, particularly in consanguineous families.
Collapse
Affiliation(s)
- Sajjad Karim
- Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-Q.); (A.A.)
- Department of Medical Lab Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
- Correspondence: ; Tel.: +966-557581741
| | - Samah Saharti
- Department of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Nofe Alganmi
- Computer Science Department, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Zeenat Mirza
- Department of Medical Lab Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
- King Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
| | - Ahmed Alfares
- Division of Genetics, Department of Pediatrics, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia;
| | - Shereen Turkistany
- Center of Innovation in Personalized Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Manal Al-Attas
- Roya Specialized Medical Laboratories, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-A.); (H.N.); (K.A.S.); (H.A.)
| | - Hend Noureldin
- Roya Specialized Medical Laboratories, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-A.); (H.N.); (K.A.S.); (H.A.)
| | - Khadega Al Sakkaf
- Roya Specialized Medical Laboratories, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-A.); (H.N.); (K.A.S.); (H.A.)
| | - Heba Abusamra
- Roya Specialized Medical Laboratories, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-A.); (H.N.); (K.A.S.); (H.A.)
| | - Mohammed Al-Qahtani
- Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-Q.); (A.A.)
| | - Adel Abuzenadah
- Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-Q.); (A.A.)
- Department of Medical Lab Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
- King Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- Roya Specialized Medical Laboratories, King Abdulaziz University, Jeddah 21589, Saudi Arabia; (M.A.-A.); (H.N.); (K.A.S.); (H.A.)
| |
Collapse
|